Develoment of analyzer for needs of up to date molecular genetic diagnostic tests
Public support
Provider
Ministry of Industry and Trade
Programme
TIP
Call for proposals
TIP 3 (SMPO2011/01)
Main participants
GeneTiCA s.r.o.
Contest type
VS - Public tender
Contract ID
FR-TI3/408
Alternative language
Project name in Czech
Vývoj analyzátoru pro potřeby moderních molekulárně genetických diagnostických testů
Annotation in Czech
Rozvoj na poli molekulárně genetických diagnostik dramaticky vzrůstá v průběhu posledních několika let a nově zjištěné informace a poznatky jsou rychle transformovány do nově vznikajících genetických testů. V současné době jsou k dispozici různé diagnostické testy, které vyžadují různou instrumentaci. Cílem projektu je vyvinout diagnostický analyzátor určený pro vlastní diagnostické kity ale i kity jiných výrobců. Za tímto účelem je velmi důležité naplnit zákonné podmínky a získat značku CE IVD. Cílem projektu je provést veškeré vyžadované testy pro získání značky CE IVD.
Scientific branches
R&D category
VV - Exeperimental development
CEP classification - main branch
FS - Medical facilities, apparatus and equipment
CEP - secondary branch
EI - Biotechnology and bionics
CEP - another secondary branch
—
OECD FORD - equivalent branches <br>(according to the <a href="http://www.vyzkum.cz/storage/att/E6EF7938F0E854BAE520AC119FB22E8D/Prevodnik_oboru_Frascati.pdf">converter</a>)
20601 - Medical engineering<br>20602 - Medical laboratory technology (including laboratory samples analysis; diagnostic technologies) (Biomaterials to be 2.9 [physical characteristics of living material as related to medical implants, devices, sensors])<br>20801 - Environmental biotechnology<br>20802 - Bioremediation, diagnostic biotechnologies (DNA chips and biosensing devices) in environmental management<br>20803 - Environmental biotechnology related ethics<br>20901 - Industrial biotechnology<br>20902 - Bioprocessing technologies (industrial processes relying on biological agents to drive the process) biocatalysis, fermentation<br>20903 - Bioproducts (products that are manufactured using biological material as feedstock) biomaterials, bioplastics, biofuels, bioderived bulk and fine chemicals, bio-derived novel materials<br>30401 - Health-related biotechnology<br>30402 - Technologies involving the manipulation of cells, tissues, organs or the whole organism (assisted reproduction)<br>30403 - Technologies involving identifying the functioning of DNA, proteins and enzymes and how they influence the onset of disease and maintenance of well-being (gene-based diagnostics and therapeutic interventions [pharmacogenomics, gene-based therapeutics])<br>30404 - Biomaterials (as related to medical implants, devices, sensors)<br>30405 - Medical biotechnology related ethics<br>40401 - Agricultural biotechnology and food biotechnology<br>40402 - GM technology (crops and livestock), livestock cloning, marker assisted selection, diagnostics (DNA chips and biosensing devices for the early/accurate detection of diseases) biomass feedstock production technologies, biopharming<br>40403 - Agricultural biotechnology related ethics
Completed project evaluation
Provider evaluation
U - Uspěl podle zadání (s publikovanými či patentovanými výsledky atd.)
Project results evaluation
The results of the project is realist DX - Diagnostic analyzer including documentation for production and certification of the analyzer at ezí. Another result is analytical software reallela.
Solution timeline
Realization period - beginning
Apr 1, 2011
Realization period - end
May 30, 2015
Project status
U - Finished project
Latest support payment
Apr 18, 2014
Data delivery to CEP
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data delivery code
CEP16-MPO-FR-U/02:1
Data delivery date
Feb 13, 2018
Finance
Total approved costs
36,800 thou. CZK
Public financial support
17,260 thou. CZK
Other public sources
0 thou. CZK
Non public and foreign sources
19,540 thou. CZK